Last updated on June 2018

QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program


Brief description of study

This phase II-III study will randomize (2:1) patients starting first-line OTT for metastatic cancer between an individualized SPEP supervised by a personal coach, and recommended physical exercises via a booklet. Eligible patients will have received 2 lines of metastatic chemotherapy, ECOG PS 2, controlled pain (VAS <3/10), and life expectancy 3 months.

Clinical Study Identifier: NCT03169075

Contact Investigators or Research Sites near you

Start Over

Laetitia Stefani, MD PhD

CH Annecy Genevois - site d'Annecy
Annecy, France
  Connect »

Florence Joly, MD PhD

Centre Fran ois Baclesse
Caen, France
  Connect »

Alain Zenatti

CH de Cholet
Cholet, France
  Connect »

Claire GARNIER-TIXIDRE

GHMG - Institut Daniel Hollard
Grenoble, France
  Connect »

Véronique GIRRE, MD PhD

CHD Vend e
La Roche-sur-Yon, France
  Connect »

Bénédicte Mastroianni

Hospices Civils de Lyon - H pital Louis Pradel
Lyon, France
  Connect »

Sébastien SALAS, MD PhD

CHU La Timone
Marseille, France
  Connect »

Sophie ABADIE-LACOURTOISIE, MD PhD

ICO Ren Gauducheau
Nantes, France
  Connect »

Claude BOIRON, PhD

Institut Curie Paris
Paris, France
  Connect »

Claudia LEFEUVRE-PLESSE, MD PhD

Centre Eug ne Marquis
Rennes, France
  Connect »

Claude Boiron, MD PhD

INSTITUT CURIE - Site Ren Huguenin St Cloud
Saint-Cloud, France
  Connect »

Nathalie Meneveau, MD PhD

CHRU de Besan on
Besançon, France
  Connect »

Nadine HOUEDE, MD PhD

CH Nimes - Institut de Canc rologie du Gard
Nîmes, France
  Connect »

Carole Helissey, MD PhD

HIA Begin
Saint-Mandé, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.